Company intelligence / Profile preview
CentricsBio
Seoul / Songpa-gu, Munjeong-dong, Seoul, Korea, Republic of / South Korea
- Ownership
- Private
- Development stage
- Other
01
Overview
CentricsBio is developing monoclonal antibody therapeutics targeting CD300c for both oncology and neurodegenerative diseases. Their lead program CB301 targets solid tumors by activating macrophages to enhance anti-tumor immunity. CB201 aims to treat Alzheimer’s disease by promoting amyloid beta clearance via activated macrophages. The company has reported promising in vivo animal data and is entering GLP toxicology studies as of mid/late 2025. Programs for autoimmune diseases are also in preclinical development.
- Therapeutic areas
- OncologyImmunologyNeurology
- Modalities
- Monoclonal antibodyBiological productsCAR-T
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →03
Partnerships
Cha University Bundang Medical Center (collaborative research contract)Networks with leading domestic and overseas research institutes
Beyond the preview
Go deeper on CentricsBio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CentricsBio.